These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 26057752)

  • 1. Cystatin C Is Not Causally Related to Coronary Artery Disease.
    Svensson-Färbom P; Almgren P; Hedblad B; Engström G; Persson M; Christensson A; Melander O
    PLoS One; 2015; 10(6):e0129269. PubMed ID: 26057752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystatin C and Risk of Diabetes and the Metabolic Syndrome - Biomarker and Genotype Association Analyses.
    Magnusson M; Molvin J; Engström G; Svensson-Färbom P; Persson M; Christensson A; Nilsson P; Melander O
    PLoS One; 2016; 11(5):e0155735. PubMed ID: 27218257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cystatin C levels are associated with coronary artery disease and its severity.
    Wang GN; Sun K; Hu DL; Wu HH; Wang XZ; Zhang JS
    Clin Biochem; 2014 Nov; 47(16-17):176-81. PubMed ID: 25084128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study.
    Keller T; Messow CM; Lubos E; Nicaud V; Wild PS; Rupprecht HJ; Bickel C; Tzikas S; Peetz D; Lackner KJ; Tiret L; Münzel TF; Blankenberg S; Schnabel RB
    Eur Heart J; 2009 Feb; 30(3):314-20. PubMed ID: 19153178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystatin C and Cardiovascular Disease: A Mendelian Randomization Study.
    van der Laan SW; Fall T; Soumaré A; Teumer A; Sedaghat S; Baumert J; Zabaneh D; van Setten J; Isgum I; Galesloot TE; Arpegård J; Amouyel P; Trompet S; Waldenberger M; Dörr M; Magnusson PK; Giedraitis V; Larsson A; Morris AP; Felix JF; Morrison AC; Franceschini N; Bis JC; Kavousi M; O'Donnell C; Drenos F; Tragante V; Munroe PB; Malik R; Dichgans M; Worrall BB; Erdmann J; Nelson CP; Samani NJ; Schunkert H; Marchini J; Patel RS; Hingorani AD; Lind L; Pedersen NL; de Graaf J; Kiemeney LA; Baumeister SE; Franco OH; Hofman A; Uitterlinden AG; Koenig W; Meisinger C; Peters A; Thorand B; Jukema JW; Eriksen BO; Toft I; Wilsgaard T; Onland-Moret NC; van der Schouw YT; Debette S; Kumari M; Svensson P; van der Harst P; Kivimaki M; Keating BJ; Sattar N; Dehghan A; Reiner AP; Ingelsson E; den Ruijter HM; de Bakker PI; Pasterkamp G; Ärnlöv J; Holmes MV; Asselbergs FW
    J Am Coll Cardiol; 2016 Aug; 68(9):934-45. PubMed ID: 27561768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced kidney function estimated by cystatin C and clinical outcomes in hypertensive patients with coronary artery disease: association with homocysteine and other cardiovascular risk factors.
    Dzielinska Z; Januszewicz A; Wiecek A; Prejbisz A; Zielinski T; Chudek J; Makowiecka-Ciesla M; Demkow M; Tyczynski P; Januszewicz M; Ruzyllo W; Naruszewicz M
    Kidney Blood Press Res; 2010; 33(2):139-48. PubMed ID: 20516698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of cystatin C in people with suspected or established coronary artery disease: A meta-analysis.
    Yang S; Song L; Zhao L; Dong P; Lai L; Wang H
    Atherosclerosis; 2017 Aug; 263():60-67. PubMed ID: 28599259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of serum cystatin C level with coronary atherosclerotic plaque burden: a comprehensive analysis of observational studies and genetic study.
    Chen J; Shen J; Pan Y; Jing J; Wang Y; Wei T; Lyu L
    BMC Cardiovasc Disord; 2023 Oct; 23(1):499. PubMed ID: 37817071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Vitamin E Levels and Risk of Coronary Artery Disease and Myocardial Infarction: A Mendelian Randomization Study.
    Wang T; Xu L
    Nutrients; 2019 Sep; 11(9):. PubMed ID: 31505768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cystatin C and adiponectin in diabetics with and without coronary artery disease].
    Wolff C; Durruty P; Espinoza J; Ripamonti S; Díaz J
    Rev Med Chil; 2009 Jun; 137(6):729-36. PubMed ID: 19746273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood CSF1 and CXCL12 as Causal Mediators of Coronary Artery Disease.
    Sjaarda J; Gerstein H; Chong M; Yusuf S; Meyre D; Anand SS; Hess S; Paré G
    J Am Coll Cardiol; 2018 Jul; 72(3):300-310. PubMed ID: 30012324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Iron Status on Risk of Coronary Artery Disease: A Mendelian Randomization Study-Brief Report.
    Gill D; Del Greco M F; Walker AP; Srai SKS; Laffan MA; Minelli C
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1788-1792. PubMed ID: 28684612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of interleukin-6 circulating levels with coronary artery disease: a meta-analysis implementing mendelian randomization approach.
    Niu W; Liu Y; Qi Y; Wu Z; Zhu D; Jin W
    Int J Cardiol; 2012 May; 157(2):243-52. PubMed ID: 22261689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum total bilirubin levels and coronary heart disease--Causal association or epiphenomenon?
    Kunutsor SK
    Exp Gerontol; 2015 Dec; 72():63-6. PubMed ID: 26408227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cystatin C in the prognosis of adverse outcomes after the coronary artery bypass graft surgery during hospitalisation.
    Shafranskaya KS; Kashtalap VV; Gruzdeva OV; Kutikhin AG; Barbarash OL; Barbarash LS
    Heart Lung Circ; 2015 Feb; 24(2):193-9. PubMed ID: 25194959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between cystatin C and coronary artery calcification in patients with intermediate cardiovascular risk].
    Ruiz-Salas A; Cortés-Rodríguez M; Alegre-Bayo N; Algarra-García J; de Teresa Galván E; Jiménez-Navarro MF
    Med Clin (Barc); 2014 Dec; 143(12):535-8. PubMed ID: 24725853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
    Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W
    Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High levels of cystatin C predict the metabolic syndrome: the prospective Malmö Diet and Cancer Study.
    Magnusson M; Hedblad B; Engström G; Persson M; Nilsson P; Melander O
    J Intern Med; 2013 Aug; 274(2):192-9. PubMed ID: 23414447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystatin C and risk of mortality among patients undergoing percutaneous coronary intervention.
    Angeli F; Verdecchia P; Savonitto S; Arraiz G; Zaninotto M; Broccatelli A; Cosma C; De Servi S; Sabino F; Briguori C; Ambrosio G; Cavallini C;
    EuroIntervention; 2015 Nov; 11(7):757-64. PubMed ID: 25136879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
    Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
    Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.